Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients
Clinical trial NCT06635447 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06635447
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-26
- Primary completion
- 2026-10-31
- Enrollment
- 293
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.